Often people bring in very long lists of medications that have been reported, once or twice, to be associated with tinnitus. This unfortunate behavior makes it very hard to care for these patients -- as it puts one into an impossible situation where the patient is in great distress but is also unwilling to attempt any treatment. Specialists who care for patients with ear disease, usually know very well which drugs are problems (such as those noted above), and which ones are nearly always safe.
Shore says her therapy isn’t for everyone — at least not yet. So far, she’s only treated patients who have a specific form of tinnitus that changes in intensity or pitch when a person moves certain parts of her body. For example, some tinnitus sufferers find the sound in their ears lessens when they clench their teeth or open their mouths wide. This suggests that some touch inputs can influence the tinnitus, Shore says. (Roughly two-thirds of tinnitus patients have this form of the condition, she adds.)
However, the multidisciplinary approach based on CBT is not a “cure for tinnitus”, as implied in some papers, but rather a system for managing its symptoms and effects on people’s lives. The differences in outcomes between the treatment and usual care groups were quite small, with the multidisciplinary approach giving a small improvement in quality of life compared with usual care, and moderate improvements in tinnitus severity and impairment. Also, less than 70% of participants completed the trial to 12 months, and this could have affected the reliability of the study’s overall results. Furthermore, as the patients in the study were only followed for 12 months, it is uncertain whether this approach can help in the longer term.
A brain tumor can be either non-cancerous (benign) or cancerous (malignant), primary, or secondary. Common symptoms of a primary brain tumor are headaches, seizures, memory problems, personality changes, and nausea and vomiting. Causes and risk factors include age, gender, family history, and exposure to chemicals. Treatment is depends upon the tumor type, grade, and location.
All materials posted on the ATA website are subject to copyright owned by the American Tinnitus Association (ATA). No part of these pages, either text, file or image may be used for any purpose other than personal use. Any reproduction, retransmissions, republication, storage in a retrieval system or retransmission, in any form or by any means, electronic, mechanical or otherwise, is strictly prohibited without prior written permission. Submit our contact form for general inquiries.